Explore the complete record of transactions filed by 명문제약. Director active across 2 companies, notably 명문제약. Cumulatively, 13 reports have been recorded. The latest transaction was filed on 30 April 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Declarations 13 total
Executives ● Purchase명 명문제약 3 DART €11,558 11,184 shares
DART:20260430000394 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase명 명문제약 12 DART DART:20260430000104 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase명 명문제약 12 DART DART:20260430000426 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase명 명문제약 12 DART DART:20260430000081 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase명 명문제약 8 DART DART:20260429000283 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) Executives ● Purchase명 명문제약 8 DART DART:20260429000321 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) Executives ● Purchase명 명문제약 8 DART DART:20260429000311 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) Executives ● Purchase명 명문제약 12 DART DART:20260429000532 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) Executives ● Purchase명 명문제약 8 DART DART:20260429000316 · 29 Apr 2026
Ideal exit: 24 Jan 2027 (T+270) DART:20260331001463 · 31 Mar 2026
DART:20260331001874 · 31 Mar 2026
Executives ● Other명 명문제약 0 DART DART:20260311003642 · 11 Mar 2026 details not loaded
DART:20260306000545 · 6 Mar 2026 details not loaded